News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
149 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21249)
Month
January (2935)
February (2968)
March (2710)
April (2908)
May (3626)
June (2409)
July (2088)
August (2590)
September (2381)
October (3064)
November (3189)
December (2222)
Day
2 (21)
3 (149)
4 (290)
5 (295)
6 (241)
7 (145)
10 (297)
11 (166)
12 (61)
13 (229)
14 (184)
17 (126)
18 (144)
19 (137)
20 (141)
21 (143)
24 (150)
25 (65)
26 (125)
27 (69)
28 (11)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
Immunology and inflammation
Neurocrine Goes to China To Grow Pipeline in up to $881M TransThera Deal
At the center of the licensing deal is an NLRP3 inhibitor that has shown “encouraging efficacy in acute inflammation models,” according to TransThera, indicating its potential in various metabolic and inflammatory diseases.
November 3, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Zelluna ASA Reports Third Quarter 2025 Financial Results and Provides General Business Update
November 3, 2025
·
3 min read
Press Releases
NeuroSigma Announces New Publication Showing Real-Time Effects of External Trigeminal Nerve Stimulation (eTNS) on Brain Activity
November 3, 2025
·
3 min read
Press Releases
Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
November 3, 2025
·
30 min read
Press Releases
BrainXell Therapeutics Unveils Promising Preclinical Data Demonstrating Efficacy of BXT-110, an Autologous iPSC-Derived Neuronal Therapy, in Parkinson’s Disease
November 3, 2025
·
2 min read
Press Releases
INNOCURA Nephrology Announces Affiliation with Kidney Care Centers
November 3, 2025
·
3 min read
Press Releases
Median Technologies Appoints Didric Cederholm to Its Board of Directors
November 3, 2025
·
4 min read
Press Releases
MaaT Pharma Announces Positive Phase 3 Results Evaluating Xervyteg® (MaaT013) in Acute Graft-versus-Host Disease Selected for Oral Presentation at ASH Congress 2025
November 3, 2025
·
7 min read
Press Releases
Recordati Rare Diseases to Share New Data at the American Society of Hematology (ASH) Meeting
November 3, 2025
·
6 min read
Press Releases
Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $13.4 Million Gross Proceeds
November 3, 2025
·
7 min read
Previous
9 of 15
Next